Transplantation of induced pluripotent stem cells improves functional recovery in Huntington's disease rat model

PLoS ONE

Volumn 9, Issue 7, 2014, Pages

  Mu, Shuhua ^a,b   Wang, Jiachuan ^b   Zhou, Guangqian ^b   Peng, Wenda ^a   He, Zhendan ^b   Zhao, Zhenfu ^b   Mo, CuiPing ^b   Qu, Junle ^a   Zhang, Jian ^a,b  

^a SHENZHEN UNIVERSITY   (China)

^b Shenzhen University School of Medicine   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM BINDING PROTEIN; FLUORODEOXYGLUCOSE F 18; GLIAL FIBRILLARY ACIDIC PROTEIN; IONIZED CALCIUM BINDING ADAPTOR MOLECULE 1; NEURON SPECIFIC NUCLEAR PROTEIN; PHOSPHOPROTEIN DARPP 32; QUINOLINIC ACID; UNCLASSIFIED DRUG; GREEN FLUORESCENT PROTEIN; NERVE PROTEIN; NEUN PROTEIN, MOUSE; NUCLEAR PROTEIN;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN ATROPHY; CELL MIGRATION; CELL SURVIVAL; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED STUDY; CORPUS STRIATUM; DISEASE MODEL; FUNCTIONAL STATUS; GLIA CELL; HISTOPATHOLOGY; HUNTINGTON CHOREA; IMMUNOHISTOCHEMISTRY; LATERAL BRAIN VENTRICLE; LEARNING; MALE; MEMORY; MORRIS WATER MAZE TEST; NERVE CELL; NERVE DEGENERATION; NONHUMAN; PLURIPOTENT STEM CELL; PROTEIN EXPRESSION; RAT; RAT MODEL; STEM CELL TRANSPLANTATION; TREATMENT RESPONSE; WESTERN BLOTTING; ANIMAL; C57BL MOUSE; CELL CULTURE; CELL DIFFERENTIATION; CHEMICALLY INDUCED; CONFOCAL MICROSCOPY; CONVALESCENCE; CYTOLOGY; DIAGNOSTIC USE; GENETICS; HUNTINGTON DISEASE; MAZE TEST; METABOLISM; MICRO-COMPUTED TOMOGRAPHY; PATHOPHYSIOLOGY; PHYSIOLOGY; POSITRON EMISSION TOMOGRAPHY; PROCEDURES; RADIOGRAPHY; SCINTISCANNING; SPRAGUE DAWLEY RAT; TRANSGENIC MOUSE; TRANSPLANTATION; XENOGRAFT;

ANIMALS; BLOTTING, WESTERN; CELL DIFFERENTIATION; CELLS, CULTURED; CORPUS STRIATUM; DISEASE MODELS, ANIMAL; FLUORODEOXYGLUCOSE F18; GLIAL FIBRILLARY ACIDIC PROTEIN; GREEN FLUORESCENT PROTEINS; HUNTINGTON DISEASE; IMMUNOHISTOCHEMISTRY; INDUCED PLURIPOTENT STEM CELLS; MALE; MAZE LEARNING; MICE, INBRED C57BL; MICE, TRANSGENIC; MICROSCOPY, CONFOCAL; NERVE TISSUE PROTEINS; NUCLEAR PROTEINS; POSITRON-EMISSION TOMOGRAPHY; QUINOLINIC ACID; RATS, SPRAGUE-DAWLEY; RECOVERY OF FUNCTION; STEM CELL TRANSPLANTATION; TRANSPLANTATION, HETEROLOGOUS; X-RAY MICROTOMOGRAPHY;

EID: 84904705471     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0101185     Document Type: Article

References (45)

1. Landles C, Bates GP (2004) Huntingtin and the molecular pathogenesis of Huntington's disease. Fourth in molecular medicine review series. EMBO Rep, 5(10): p. 958-63. (Pubitemid 39534452)
2. Vonsattel JP, Myers RH, Stevens TJ, Ferrante RJ, Bird ED, et al. (1985) Neuropathological classification of Huntington's disease. J Neuropathol Exp Neurol, 44(6): p. 559-77. (Pubitemid 16196286)
3. Freeman TB, Hauser RA, Sanberg PR, Saporta S (2000) Neural transplantation for the treatment of Huntington's disease. Prog Brain Res, 127: p. 405-11. (Pubitemid 35461268)
4. Visnyei K, Tatsukawa KJ, Erickson RI, Simonian S, Oknaian N, et al. (2006) Neural progenitor implantation restores metabolic deficits in the brain following striatal quinolinic acid lesion. Exp Neurol, 197(2): p. 465-74. (Pubitemid 43077155)
5. Ramaswamy S, Shannon KM, Kordower JH (2007) Huntington's disease: pathological mechanisms and therapeutic strategies. Cell Transplant, 16(3): p. 301-12. (Pubitemid 47300233)
6. Payne NL, Sylvain A, O'Brien C, Herszfeld D, Sun G, et al. (2014) Application of human induced pluripotent stem cells for modeling and treating neurodegenerative diseases. N Biotechnol.
7. Bachoud-Levi AC, Remy P, Nguyen JP, Brugieres P, Lefaucheur JP, et al. (2000) Motor and cognitive improvements in patients with Huntington's disease after neural transplantation. Lancet, 356(9246): p. 1975-9.
8. Keene CD, Sonnen JA, Swanson PD, Kopyov O, Leverenz JB, et al. (2007) Neural transplantation in Huntington disease: long-term grafts in two patients. Neurology, 68(24): p. 2093-8. (Pubitemid 46912127)
9. Bjorklund A (1993) Neurobiology. Better cells for brain repair. Nature, 362(6419): p. 414-5.
10. Takahashi K, Yamanaka S (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell, 126(4): p. 663-76. (Pubitemid 44233629)
11. Tornero D, Wattananit S, Gronning Madsen M, Koch P, Wood J, et al. (2013) Human induced pluripotent stem cell-derived cortical neurons integrate in stroke-injured cortex and improve functional recovery. Brain.
12. Wang J, Chao F, Han F, Zhang G, Xi Q, et al. (2013) PET demonstrates functional recovery after transplantation of induced pluripotent stem cells in a rat model of cerebral ischemic injury. J Nucl Med, 54(5): p. 785-92.
13. Tsuji O, Miura K, Okada Y, Fujiyoshi K, Mukaino M, et al. (2010) Therapeutic potential of appropriately evaluated safe-induced pluripotent stem cells for spinal cord injury. Proc Natl Acad Sci U S A, 107(28): p. 12704-9.
14. Nori S, Okada Y, Yasuda A, Tsuji O, Takahashi Y, et al. (2011) Grafted human-induced pluripotent stem-cell-derived neurospheres promote motor functional recovery after spinal cord injury in mice. Proc Natl Acad Sci U S A, 108(40): p. 16825-30.
15. Sundberg M, Bogetofte H, Lawson T, Jansson J, Smith G, et al. (2013) Improved cell therapy protocols for Parkinson's disease based on differentiation efficiency and safety of hESC-, hiPSC-, and non-human primate iPSC-derived dopaminergic neurons. Stem Cells, 31(8): p. 1548-62.
16. Hargus G, Cooper O, Deleidi M, Levy A, Lee K, et al. (2010) Differentiated Parkinson patient-derived induced pluripotent stem cells grow in the adult rodent brain and reduce motor asymmetry in Parkinsonian rats. Proc Natl Acad Sci U S A, 107(36): p. 15921-6.
17. Zhang Y, Ruel M, Beanlands RS, deKemp RA, Suuronen EJ, et al. (2008) Tracking stem cell therapy in the myocardium: applications of positron emission tomography. Curr Pharm Des, 14(36): p. 3835-53.
18. Jiang H, Cheng Z, Tian M, Zhang H (2011) In vivo imaging of embryonic stem cell therapy. Eur J Nucl Med Mol Imaging, 38(4): p. 774-84.
19. Kuwert T, Lange HW, Langen KJ, Herzog H, Aulich A, et al. (1990) Cortical and subcortical glucose consumption measured by PET in patients with Huntington's disease. Brain, 113 (Pt 5): p. 1405-23. (Pubitemid 20385921)
20. Antonini A, Leenders KL, Spiegel R, Meier D, Vontobel P, et al. (1996) Striatal glucose metabolism and dopamine D2 receptor binding in asymptomatic gene carriers and patients with Huntington's disease. Brain, 119 (Pt 6): p. 2085-95. (Pubitemid 27032638)
21. Zhang H, Zheng X, Yang X, Fang S, Shen G, et al. (2008) 11C-NMSP/18FFDG microPET to monitor neural stem cell transplantation in a rat model of traumatic brain injury. Eur J Nucl Med Mol Imaging, 35(9): p. 1699-708.
22. Shyu WC, Li KW, Peng HF, Lin SZ, Liu RS, et al. (2009) Induction of GAP-43 modulates neuroplasticity in PBSC (CD34+) implanted-Parkinson's model. J Neurosci Res, 87(9): p. 2020-33.
23. Lione LA, Carter RJ, Hunt MJ, Bates GP, Morton AJ, et al. (1999) Selective discrimination learning impairments in mice expressing the human Huntington's disease mutation. J Neurosci, 19(23): p. 10428-37. (Pubitemid 30228050)
24. Mu S, OuYang L, Liu B, Zhu Y, Li K, et al. (2011) Preferential interneuron survival in the transition zone of 3-NP-induced striatal injury in rats. J Neurosci Res, 89(5): p. 744-54.
25. Vorhees CV, Williams MT (2006) Morris water maze: procedures for assessing spatial and related forms of learning and memory. Nat Protoc, 1(2): p. 848-58.
26. Araujo DM, Cherry SR, Tatsukawa KJ, Toyokuni T, Kornblum HI (2000) Deficits in striatal dopamine D(2) receptors and energy metabolism detected by in vivo microPET imaging in a rat model of Huntington's disease. Exp Neurol, 166(2): p. 287-97.
27. Lee ST, Chu K, Jung KH, Im WS, Park JE, et al. (2009) Slowed progression in models of Huntington disease by adipose stem cell transplantation. Ann Neurol, 66(5): p. 671-81.
28. Paxinos G, Watson (1986) The Rat Brain in Stereotaxic Coordinates.
29. Jueptner M, Weiller C (1995) Review: does measurement of regional cerebral blood flow reflect synaptic activity? Implications for PET and fMRI. Neuroimage, 2(2): p. 148-56.
30. Feigin A, Leenders KL, Moeller JR, Missimer J, Kuenig G, et al. (2001) Metabolic network abnormalities in early Huntington's disease: an [(18)F]FDG PET study. J Nucl Med, 42(11): p. 1591-5. (Pubitemid 33131316)
31. Wang X, Sarkar A, Cicchetti F, Yu M, Zhu A, et al. (2005) Cerebral PET imaging and histological evidence of transglutaminase inhibitor cystamine induced neuroprotection in transgenic R6/2 mouse model of Huntington's disease. J Neurol Sci, 231(1-2): p. 57-66. (Pubitemid 40439235)
32. Gaura V, Bachoud-Levi AC, Ribeiro MJ, Nguyen JP, Frouin V, et al. (2004) Striatal neural grafting improves cortical metabolism in Huntington's disease patients. Brain, 127(Pt 1): p. 65-72. (Pubitemid 38055346)
33. Arvidsson A, Collin T, Kirik D, Kokaia Z, Lindvall O (2002) Neuronal replacement from endogenous precursors in the adult brain after stroke. Nat Med, 8(9): p. 963-70. (Pubitemid 35033700)
34. Lin YT, Chern Y, Shen CK, Wen HL, Chang YC, et al. (2011) Human mesenchymal stem cells prolong survival and ameliorate motor deficit through trophic support in Huntington's disease mouse models. PLoS One, 6(8): p. e22924.
35. Feng M, Zhu H, Zhu Z, Wei J, Lu S, et al. (2011) Serial 18F-FDG PET demonstrates benefit of human mesenchymal stem cells in treatment of intracerebral hematoma: a translational study in a primate model. J Nucl Med, 52(1): p. 90-7.
36. Sadan O, Shemesh N, Barzilay R, Dadon-Nahum M, Blumenfeld-Katzir T, et al. (2012) Mesenchymal stem cells induced to secrete neurotrophic factors attenuate quinolinic acid toxicity: a potential therapy for Huntington's disease. Exp Neurol, 234(2): p. 417-27.
37. Emerich DF, Thanos CG, Goddard M, Skinner SJ, Geany MS, et al. (2006) Extensive neuroprotection by choroid plexus transplants in excitotoxin lesioned monkeys. Neurobiol Dis, 23(2): p. 471-80. (Pubitemid 44097036)
38. Chung WS, Clarke LE, Wang GX, Stafford BK, Sher A, et al. (2013) Astrocytes mediate synapse elimination through MEGF10 and MERTK pathways. Nature, 504(7480): p. 394-400.
39. Borlongan CV, Yamamoto M, Takei N, Kumazaki M, Ungsuparkorn C, et al. (2000) Glial cell survival is enhanced during melatonin-induced neuroprotection against cerebral ischemia. Faseb J, 14(10): p. 1307-17. (Pubitemid 30439739)
40. Dusart I, Marty S, Peschanski M (1991) Glial changes following an excitotoxic lesion in the CNS - II. Astrocytes. Neuroscience, 45(3): p. 541-9.
41. Benner EJ, Luciano D, Jo R, Abdi K, Paez-Gonzalez P, et al. (2013) Protective astrogenesis from the SVZ niche after injury is controlled by Notch modulator Thbs4. Nature, 497(7449): p. 369-73.
42. Shin JY, Fang ZH, Yu ZX, Wang CE, Li SH, et al. (2005) Expression of mutant huntingtin in glial cells contributes to neuronal excitotoxicity. J Cell Biol, 171(6): p. 1001-12. (Pubitemid 41815832)
43. Acarin L, Gonzalez B, Castellano B (2000) Neuronal, astroglial and microglial cytokine expression after an excitotoxic lesion in the immature rat brain. Eur J Neurosci, 12(10): p. 3505-20.
44. Marco S, Canudas AM, Canals JM, Gavalda N, Perez-Navarro E, et al. (2002) Excitatory amino acids differentially regulate the expression of GDNF, neurturin, and their receptors in the adult rat striatum. Exp Neurol, 174(2): p. 243-52. (Pubitemid 34293452)
45. Strauss S, Otten U, Joggerst B, Pluss KVolk B (1994) Increased levels of nerve growth factor (NGF) protein and mRNA and reactive gliosis following kainic acid injection into the rat striatum. Neurosci Lett, 168(1-2): p. 193-6. (Pubitemid 24097355)